Flt3 ligand expands CD4+FoxP3+ regulatory T cells in human subjects

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 533-539

  Klein, Oliver ^a   Ebert, Lisa M ^a,d   Zanker, Damien ^a   Woods, Katherine ^a   Tan, Bee Shin ^a   Fucikova, Jitka ^a,b   Behren, Andreas ^a   Davis, Ian D ^a   Maraskovsky, Eugene ^c   Chen, Weisan ^a   Cebon, Jonathan ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c CSL LIMITED   (Australia)

^d CENTRE FOR CANCER BIOLOGY   (Australia)

Author keywords

Flt3 ligand; Immune tolerance; Regulatory T (Treg) cells

Indexed keywords

FLT3 LIGAND; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CD4+ FOXP3+ REGULATORY T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID PROGENITOR CELL; MONOCYTE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL GROWTH PROCESSES; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MYELOID CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84873750260     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242603     Document Type: Article

References (31)

1. Wing, K. and Sakaguchi, S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010. 11: 7-13.
2. Riley, J. L., June, C. H. and Blazar, B. R., Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009. 30: 656-665.
3. + regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 2009. 39: 1088-1097.
4. Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C. H., Hanke, T. et al., Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J. Exp. Med. 2005. 202: 445-455.
5. Webster, K. E., Walters, S., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T. et al., In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 2009. 206: 751-760.
6. Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D. and Panoskaltsis, N., Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 2006. 355: 1018-1028.
7. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K. and McKenna, H. J., Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996. 184: 1953-1962.
8. Maraskovsky, E., Daro, E., Roux, E., Teepe, M., Maliszewski, C. R., Hoek, J., Caron, D. et al., In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000. 96: 878-884.
9. Pulendran, B., Banchereau, J., Burkeholder, S., Kraus, E., Guinet, E., Chalouni, C., Caron, D. et al., Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 2000. 165: 566-572.
10. Darrasse-Jeze, G., Deroubaix, S., Mouquet, H., Victora, G. D., Eisenreich, T., Yao, K. H., Masilamani, R. F. et al., Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009. 206: 1853-1862.
11. Swee, L. K., Bosco, N., Malissen, B., Ceredig, R. and Rolink, A., Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood 2009. 113: 6277-6287.
12. Collins, C. B., Aherne, C. M., McNamee, E. N., Lebsack, M. D., Eltzschig, H., Jedlicka, P. and Rivera-Nieves, J., Flt3 ligand expands CD103(+) dendritic cells and FoxP3(+) T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut 2011. 61: 1154-1162.
13. + T reg cells. J. Exp. Med. 2006. 203: 1701-1711.
14. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 1693-1700.
15. Rosnet, O., Schiff, C., Pebusque, M. J., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F. et al., Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993. 82: 1110-1119.
16. Astier, A. L., Beriou, G., Eisenhaure, T. M., Anderton, S. M., Hafler, D. A. and Hacohen, N., RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 2010. 184: 685-693.
17. Wils, E. J., Braakman, E., Verjans, G. M., Rombouts, E. J., Broers, A. E., Niesters, H. G., Wagemaker, G. et al., Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation. J. Immunol. 2007. 178: 3551-3557.
18. Kimmig, S., Przybylski, G. K., Schmidt, C. A., Laurisch, K., Mowes, B., Radbruch, A. and Thiel, A., Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 2002. 195: 789-794.
19. + T regulatory cells. J. Immunol. 2010. 184: 3433-3441.
20. + T regulatory cells". J. Immunol. 2010. 185: 7129-7130.
21. + regulatory T cells in the steady state. J. Exp. Med. 2003. 198: 737-746.
22. Zou, T., Caton, A. J., Koretzky, G. A. and Kambayashi, T., Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J. Immunol. 2010. 185: 2790-2799.
23. + regulatory T cells. J. Immunol. 2008. 181: 6923-6933.
24. Robbins, S. H., Walzer, T., Dembele, D., Thibault, C., Defays, A., Bessou, G., Xu, H. et al., Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome. Biol. 2008. 9: R17.
25. Bigley, V., Haniffa, M., Doulatov, S., Wang, X. N., Dickinson, R., McGovern, N., Jardine, L. et al., The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J. Exp. Med. 2011. 208: 227-234.
26. Seneschal, J., Clark, R. A., Gehad, A., Baecher-Allan, C. M. and Kupper, T. S., Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 2012. 36: 873-884.
27. Shackleton, M., Davis, I. D., Hopkins, W., Jackson, H., Dimopoulos, N., Tai, T., Chen, Q. et al., The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Cancer. Immun. 2004. 4: 9.
28. Koreth, J., Matsuoka, K., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., , Armand, P. et al., Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 2011. 365: 2055-2066.
29. Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D. et al., Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 2011. 365: 2067-2077.
30. + T cells in a dose-dependent fashion. Blood 2008. 112: 1175-1183.
31. Schnurr, M., Toy, T., Stoitzner, P., Cameron, P., Shin, A., Beecroft, T., Davis, I. D. et al., ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 2003. 102: 613-620.